Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women. Issue 6 (31st May 2018)

• Record Type: Journal Article
• Authors: Aoyama‐Kikawa, Satomi; Fujita, Hiromasa; Hanley, Sharon J.B.; Kasamo, Mitsunori; Kikuchi, Kokichi; Torigoe, Toshihiko; Matsuno, Yoshihiro; Tamakoshi, Akiko; Sasaki, Takayuki; Matsuura, Motoki; Kato, Yasuhito; Dong, Peixin; Watari, Hidemichi; Saito, Tsuyoshi; Sengoku, Kazuo; Sakuragi, Noriaki
• Is Part Of: Cancer science. Volume 109:Issue 6(2018)
• Page Start: 2003
• Page End: 2012
• Publication Date: 2018-05-31
• Subjects: cervical cancer screening -- COMPACT Study -- human papillomavirus deoxyribonucleic acid testing -- partial genotyping -- triage; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.13608
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract : Although cytology‐based screening programs have significantly reduced mortality and morbidity from cervical cancer, the global consensus is that primary human papillomavirus (HPV) testing for cervical screening increases detection of high‐grade cervical intraepithelial neoplasia (CIN) and invasive cancer. However, the optimal triage strategy for HPV‐positive women to avoid over‐referral to colposcopy may be setting specific. As Japan requires data that have been generated domestically to modify screening guidelines, we conducted a 3‐year prospective study, COMparison of HPV genotyping And Cytology Triage (COMPACT), to evaluate the potential role of HPV16/18 partial genotyping and cytology for primary HPV screening. In total, 14 642 women aged 20 to 69 years undergoing routine screening at 3 centers in Hokkaido were enrolled. Conventional cytology and HPV testing were carried out. Women with abnormal cytology or HPV16/18 positivity underwent colposcopy. Those with 12 other high‐risk (hr) HPV types underwent repeat cytology after 6 months. Primary study endpoints were detection of high‐grade cervical disease defined as CIN2/CIN3 or greater as determined by consensus pathology. Prevalence of cytological abnormalities was 2.4%. hrHPV, HPV 16, and HPV 18 were detected in 4.6%, 0.9%, and 0.3% of women, respectively. HPV16/18 were detected in all (8/8) invasive cervical cancers and in all (2/2) adenocarcinomas in situ. Both cytological abnormalities and hrHPV positivity declined with increasing age. This is the first Japanese study to investigate the role of partial genotyping and cytology in an HPV‐based screening program. Results should help policy‐makers develop guidelines for future cervical screening programs and management of cervical abnormalities based on HPV genotype. Abstract : Primary human papillomavirus (HPV) testing for cervical screening increases detection of high‐grade cervical intraepithelial neoplasia (CIN) and invasive cancer compared to cytology. However, the optimal triage strategy for HPV‐positive women to avoid over‐referral to colposcopy may be setting specific. A 3‐year prospective study COMparison of HPV genotyping And Cytology Triage (COMPACT) was conducted to evaluate the potential role of HPV16/18 partial genotyping and cytology for primary HPV screening in Japan.